![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
MO Urban and DJ Smith
Department of Anesthesiology, West Virginia University, Morgantown.
These studies examined the role of the neurotensinergic projections extending from the periaqueductal gray (PAG) to the nucleus raphe magnus (NRM) on the inhibition of the tail-flick reflex produced by microinjection of morphine or beta-endorphin in the PAG. Neurotensin (3- 30 nmol) or the partial agonist [D-Trp11] neurotensin (100 and 300 pmol) microinjected into the NRM of awake rats produced a dose- dependent inhibition of the tail-flick response lasting 90 to 150 min. Lower doses of neurotensin (0.03-0.3 nmol) produced a hyperreflexive tail-flick response 10 min after injection, which correlated with a decreased hot plate latency. Additionally, a dose of [D- Trp11]neurotensin (3 pmol) that had no intrinsic activity antagonized both the antinociceptive as well as hyperreflexive responses of neurotensin. Morphine (6 nmol) injected into the PAG produced an inhibition of the tail-flick response that was enhanced by injection of [D-Trp11]neurotensin (3 pmol) into the NRM. In contrast, injection of [D-Trp11]neurotensin (3 pmol) into the NRM had no effect on the inhibition of the tail-flick produced by beta-endorphin (10 nmol) in the PAG. Antineurotensin antiserum yielded results similar to those obtained with [D-Trp11]neurotensin. Although neurotensin was found to produce changes in tail skin temperature, it was possible to dissociate these effects from changes in tail-flick latency. These data suggest that neurotensin produces both antinociceptive and hyperalgesic responses when injected into the NRM.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  J. Fichna, A. Janecka, J. Costentin, and J.-C. Do Rego The Endomorphin System and Its Evolving Neurophysiological Role Pharmacol. Rev., March 1, 2007; 59(1): 88 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sarret, M. J. Esdaile, A. Perron, J. Martinez, T. Stroh, and A. Beaudet Potent Spinal Analgesia Elicited through Stimulation of NTS2 Neurotensin Receptors J. Neurosci., September 7, 2005; 25(36): 8188 - 8196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Heinricher, S. McGaraughty, and V. Tortorici Circuitry Underlying Antiopioid Actions of Cholecystokinin Within the Rostral Ventromedial Medulla J Neurophysiol, January 1, 2001; 85(1): 280 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. O. Urban and G. F. Gebhart Supraspinal contributions to hyperalgesia PNAS, July 6, 1999; 96(14): 7687 - 7692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. O. Urban, S. V. Coutinho, and G. F. Gebhart Biphasic Modulation of Visceral Nociception by Neurotensin in Rat Rostral Ventromedial Medulla J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 207 - 213. [Abstract] [Full Text]
|
|
|
|
|
|
J. J. Rady, W. Lin, and J. M. Fujimoto Pentobarbital Antagonism of Morphine Analgesia Mediated by Spinal Cholecystokinin J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 878 - 885. [Abstract] [Full Text]
|
|
|
|
|
|
M. O. Urban and G. F. Gebhart Characterization of Biphasic Modulation of Spinal Nociceptive Transmission by Neurotensin in the Rat Rostral Ventromedial Medulla J Neurophysiol, September 1, 1997; 78(3): 1550 - 1562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Smith, A. A. Hawranko, P. J. Monroe, D. Gully, M. O. Urban, C. R. Craig, J. P. Smith, and D. L. Smith Dose-Dependent Pain-Facilitatory and -Inhibitory Actions of Neurotensin Are Revealed by SR 48692, a Nonpeptide Neurotensin Antagonist: Influence on the Antinociceptive Effect of Morphine, J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 899 - 908. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
